About Conatus Pharma
Conatus Pharma is a company based in San Diego (United States) founded in 2005. Conatus Pharma has raised $67.38 million across 7 funding rounds from investors including Novartis, Genechem and Turmeric Acquisition Corp. The company has 22 employees as of December 31, 2021. Conatus Pharma offers products and services including Levitra, Doxycycline, Viagra, and Kamagra. Conatus Pharma operates in a competitive market with competitors including Capsule, Blink Health, NimbleRx, Phil and Scriptdrop, among others.
- Headquarter San Diego, United States
- Employees 22 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Histogen Inc.
-
Annual Revenue
$3.77 M (USD)265as on Dec 31, 2022
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$67.38 M (USD)
in 7 rounds
-
Latest Funding Round
$50 M (USD), Debt – Conventional
Dec 19, 2016
-
Investors
Novartis
& 7 more
-
Employee Count
22
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Conatus Pharma
Conatus Pharma offers a comprehensive portfolio of products and services, including Levitra, Doxycycline, Viagra, and Kamagra.
Medication for treating erectile dysfunction symptoms.
Antibiotic used for bacterial infections and related conditions.
Drug for managing erectile dysfunction effectively.
Sildenafil-based medication for erectile dysfunction relief.
People of Conatus Pharma
Unlock access to complete
Funding Insights of Conatus Pharma
Conatus Pharma has successfully raised a total of $67.38M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $50 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Conatus Pharma
Conatus Pharma has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Novartis, Genechem and Turmeric Acquisition Corp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US Life-Sciences sectors are targeted for investment by Aberdare Ventures.
|
Locked | Locked | Locked | |
|
Stage-agnostic investments in US life-sciences sectors are managed.
|
Locked | Locked | Locked | |
|
Early and mid-stage life science focused VC firm investing in the US and Europe
|
Locked | Locked | Locked |
Investor details for Conatus Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Conatus Pharma
Investment portfolio details for Conatus Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Conatus Pharma
Detailed financials for Conatus Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Conatus Pharma Comparisons
Peer comparison for Conatus Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Conatus Pharma
Conatus Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Capsule, Blink Health, NimbleRx, Phil and Scriptdrop, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An online pharmacy platform is operated for medicine delivery services.
|
|
| Locked | Locked | Locked |
Discounted prescription drugs are provided via an online pharmacy platform.
|
|
| Locked | Locked | Locked |
Prescriptions are delivered same-day through an online platform.
|
|
| Locked | Locked | Locked |
Prescription drugs refill management solutions
|
|
| Locked | Locked | Locked |
On-demand prescription delivery is facilitated for patients through pharmacists' workflows.
|
|
| Locked | Locked | Locked |
Software is offered for executive assistants' task tracking and scheduling.
|
Detailed competitors of Conatus Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Conatus Pharma
Complete news archive for Conatus Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Conatus Pharma
Conatus Pharma was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Conatus Pharma is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Steven J Mento is the current CEO of Conatus Pharma.
Conatus Pharma is a funded company, having raised a total of $67.38M across 7 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Conatus Pharma is 22.
Annual revenue of Conatus Pharma is $3.77M as on Dec 31, 2022.
Conatus is focused on the development and commercialization of novel medicines to treat liver disease. Lead compound, emricasan, is an orally active pan-caspase protease inhibitor designed to reduce the activity of human caspases, which are enzymes that mediate inflammation and apoptosis. By reducing the activity of these enzymes, emricasan has the potential to interrupt the progression of liver disease and potentially provide treatment options in multiple areas of liver disease. Phase 2 results for emricasan have been published as of now for portal hypertension and liver cirrhosis. Conatus acquired idun subsidiary of pfizer in 2015 to expand its therapeutic reach to oncology.
Conatus Pharma's top competitors include Capsule, Blink Health and Phil.
Conatus Pharma offers Levitra, Doxycycline, Viagra, and Kamagra.
Conatus Pharma has 8 investors. Key investors include Novartis, Genechem, Turmeric Acquisition Corp, Aberdare Ventures, and Bay City Capital.